Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nu Holdings
NU
|
+$91.9M |
| 2 |
SW
Smurfit Westrock plc
SW
|
+$76.1M |
| 3 |
Pinduoduo
PDD
|
+$30.9M |
| 4 |
Microsoft
MSFT
|
+$24.9M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$22.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$122M |
| 2 |
Apple
AAPL
|
+$45.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$29M |
| 5 |
Flutter Entertainment
FLUT
|
+$20.3M |
Sector Composition
| 1 | Technology | 32.64% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.2% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Sally Beauty Holdings
SBH
$1.45B
| $2.74M | ﹤0.01% |
202,100
-4,300
| -2% | -$58.4K |
|
1677
Wolverine World Wide
WWW
$2.51B
| $2.73M | ﹤0.01% |
156,700
| – | – |
|
|
ALEX
1678
Alexander & Baldwin
ALEX
$1.36B
| $2.72M | ﹤0.01% |
141,820
-1,300
| -0.9% | -$25K |
|
1679
Customers Bancorp
CUBI
$2.35B
| $2.72M | ﹤0.01% |
58,600
| – | – |
|
1680
Skyward Specialty Insurance
SKWD
$1.93B
| $2.72M | ﹤0.01% |
66,800
| – | – |
|
1681
Dynavax Technologies
DVAX
$1.14B
| $2.72M | ﹤0.01% |
244,078
| – | – |
|
1682
REV Group
REVG
$3.06B
| $2.72M | ﹤0.01% |
96,900
| – | – |
|
|
MAG
1683
DELISTED
MAG Silver
MAG
| $2.72M | ﹤0.01% |
192,700
-1,100
| -0.6% | -$15.5K |
|
1684
Akero Therapeutics
AKRO
$3.59B
| $2.71M | ﹤0.01% |
94,500
-7,500
| -7% | -$215K |
|
1685
Perdoceo Education
PRDO
$2.16B
| $2.71M | ﹤0.01% |
121,700
-7,600
| -6% | -$169K |
|
1686
Dana Inc
DAN
$2.73B
| $2.7M | ﹤0.01% |
256,100
| – | – |
|
1687
DNOW Inc
DNOW
$1.61B
| $2.7M | ﹤0.01% |
208,600
-5,700
| -3% | -$73.7K |
|
|
SILV
1688
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $2.69M | ﹤0.01% |
289,600
-2,100
| -0.7% | -$19.5K |
|
1689
Mirum Pharmaceuticals
MIRM
$3.82B
| $2.69M | ﹤0.01% |
69,000
+4,200
| +6% | +$164K |
|
1690
Warby Parker
WRBY
$3.29B
| $2.69M | ﹤0.01% |
164,500
| – | – |
|
1691
AtriCure
ATRC
$1.75B
| $2.67M | ﹤0.01% |
95,100
| – | – |
|
1692
VSE Corp
VSEC
$3.45B
| $2.66M | ﹤0.01% |
32,178
+300
| +0.9% | +$24.8K |
|
1693
Lindsay Corp
LNN
$1.5B
| $2.65M | ﹤0.01% |
21,300
-400
| -2% | -$49.9K |
|
|
NVEE
1694
DELISTED
NV5 Global
NVEE
| $2.65M | ﹤0.01% |
113,600
+800
| +0.7% | +$18.7K |
|
1695
JELD-WEN Holding
JELD
$537M
| $2.65M | ﹤0.01% |
167,900
| – | – |
|
1696
Worthington Enterprises
WOR
$3.22B
| $2.65M | ﹤0.01% |
64,000
| – | – |
|
1697
Cimpress
CMPR
$1.44B
| $2.65M | ﹤0.01% |
32,300
-1,800
| -5% | -$147K |
|
1698
Harrow
HROW
$1.44B
| $2.64M | ﹤0.01% |
+58,700
| New | +$2.64M |
|
1699
Enovix
ENVX
$1.74B
| $2.63M | ﹤0.01% |
321,829
| – | – |
|
1700
Ingevity
NGVT
$2.08B
| $2.63M | ﹤0.01% |
67,390
-500
| -0.7% | -$19.5K |
|